IVD Distribution Network
— The neural network and value foundation of China’s healthcare ecosystem
China’s Leading IVD Distributor
The first curve of ETHK Labs is built on three decades of focus and persistence. It is more than a distribution business — it is the native foundation that lets us understand China’s healthcare system and anchors every future strategy.
Through our subsidiary Wisdor, we have been Sysmex’s exclusive coagulation partner in China since 1997, bringing world-class diagnostics into clinical practice. We have installed over 6,600 coagulation analyzers, built a network across 31 provinces and regions, serve 236 direct clients and 1,073 distributor nodes, and reach more than 1,700 tier-3 hospitals nationwide.
The ultimate value of this curve goes far beyond commercial numbers. It gives us three strategic assets:
Deep Ecosystem Insight
We operate at the front line of clinical demand every day. This gives us ground-truth insight into unmet needs, real-world adoption, and policy impact — an indispensable signal for identifying the next wave of medical innovation.
A Trusted Network
Decades of professional service have earned trust well beyond transactions. That trust is the passport and accelerator for new AI solutions to enter clinical practice and scale.
Data Entry for Collaboration
A large installed base and high-volume reagent usage create a stable, high-quality data source. Coupled with clinical context, this enables algorithm training and validation with unique leverage.
This is why our first curve is the unique advantage of ETHK Labs as an AI healthcare capital platform. It ensures each acquisition and integration is grounded in the most authentic understanding of China’s healthcare ecosystem.
In 2024, the top five competitors in the primary coagulation IVD distribution market held about 47.2% combined share, with Wisdor ranking #1 at 31.2%.
High-density distribution network
across 31 provinces
Core Value of the IVD Distribution Network (K1)
The first curve is more than distribution. It is the core infrastructure we have built in China’s healthcare market over nearly three decades, and a foundational engine in our strategy as a global AI healthcare capital platform.
Deep-Insight Ecosystem Network
A “super sensor” for China’s healthcare marketA network spanning 31 provinces and 1,700+ tier-3 hospitals is a real-time value sensor. It lets us detect clinical needs, adoption pain points, and market evolution — a unique decision foundation for identifying AI healthcare leaders globally.
Data and Scenario Access
The validation field and amplifier for AI valueMore than 6,600 installed instruments and their structured data streams create authentic real-world scenarios. Acquired AI assets can enter clinical settings quickly, validate value, and iterate. K1 becomes the bridge from knowledge to scalable solutions.
Commercialization Engine
A growth accelerator for portfolio companiesFor ecosystem members, the network delivers unmatched speed to market. It lowers commercialization barriers, shortens adoption cycles, and drives rapid value compounding across the ecosystem.